The association of the metabolic syndrome with QTc interval in NHANES III

European Journal of Epidemiology

Volumn 23, Issue 7, 2008, Pages 459-465

  Faramawi, Mohammed F ^a   Wildman, Rachel P ^b   Gustat, Jeanette ^c   Rice, Janet ^c   Abdul Kareem, Mohammed Y ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

Cross sectional studies; Electrocardiography; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FATALITY; FEMALE; HEART ARRHYTHMIA; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; QT INTERVAL; UNITED STATES;

ARRHYTHMIAS, CARDIAC; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; UNITED STATES;

EID: 45849134112     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-008-9252-4     Document Type: Article

References (37)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287(3):356-9.
2. Gogia A, Agarwal PK. Metabolic syndrome. Indian J Med Sci. 2006;60(2):72-81.
3. Lahoz C, Vicente I, Laguna F, Garcia-Iglesias MF, Taboada M, Mostaza JM. Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age. Diabetes Care. 2006;29(1):148-50.
4. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-50.
5. Soydinc S, Davutoglu V, Akcay M. Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol. 2006;11(4):313-7.
6. Rebeiz AG, Al-Khatib SM. A case of severe ischemia-induced QT prolongation. Clin Cardiol. 2001;24(11):750.
7. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362-7.
8. Sharp DS, Masaki K, Burchfiel CM, Yano K, Schatz IJ. Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men. Ann Epidemiol. 1998;8(2):99-106.
9. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation. 2000;101(1):61-6.
10. Nakanishi S, Yamada M, Hattori N, Suzuki G. Relation between QT duration and mortality in an elderly Japanese population. Am J Cardiol. 2004;93(9):1182-5.
11. Rautaharju PM, Nelson JC, Kronmal RA, Zhang ZM, Robbins J, Gottdiener JS, et al. Usefulness of T-axis deviation as an independent risk indicator for incident cardiac events in older men and women free from coronary heart disease (the Cardiovascular Health Study). Am J Cardiol. 2001;88(2):118-23.
12. Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther. 2003;10(6):452-7.
13. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013-22.
14. Liu XK, Katchman A, Drici MD, Ebert SN, Ducic I, Morad M, et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther. 1998;285(2):672-9.
15. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: Programs and collection procedures. Vital Health Stat. 1994;1:1-407.
16. Neeley WE. Simple automated determination of serum or plasma glucose by a hexokinase-glucose-6-phosphate dehydrogenase method. Clin Chem. 1972;18(6):509-15.
17. Gunter EW, Lewis B, Koncikowski SM. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 Centers for Disease Control and Prevention. Hyattsville, MD; 1996
18. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13-8.
19. Cardenas VM, Graham DY. Smoking and Helicobacter pylori infection in a sample of U.S. adults. Epidemiology. 2005;16(4):586-90.
20. Weitzman M, Cook S, Auinger P, Florin TA, Daniels S, Nguyen M, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2005;112(6):862-9.
21. Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil. 2005;12(4):363-8.
22. Fridericia LS. The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920. Ann Noninvasive Electrocardiol. 2003;8(4):343-51.
23. Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, et al. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J. 1988;59(3):379-83.
24. Dekker JM, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen study. Circulation. 1994;90(2):779-85.
25. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991;84(4):1516-23.
26. Leclercq B, Jaimes EA, Raij L. Nitric oxide synthase and hypertension. Curr Opin Nephrol Hypertens. 2002;11(2):185-9.
27. Ahnve S. QT interval prolongation in acute myocardial infarction. Eur Heart J. 1985;6 (Suppl D):85-95
28. Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J. 1985;109(3 Pt 1):568-74.
29. Alonso JL, Martinez P, Vallverdu M, Cygankiewicz I, Pitzalis MV, Bayes Genis A, et al. Dynamics of ventricular repolarization in patients with dilated cardiomyopathy versus healthy subjects. Ann Noninvasive Electrocardiol. 2005;10(2):121-8.
30. Milliez P, Leenhardt A, Maisonblanche P, Vicaut E, Badilini F, Siliste C, et al. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). Am J Cardiol. 2005;95(7):821-6.
31. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27(10):2444-9.
32. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, National Cholesterol Education Program N. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52(5):1210-4.
33. Tong W, Lai H, Yang C, Ren S, Dai S, Lai S. Age, gender and metabolic syndrome-related coronary heart disease in U.S. adults. Int J Cardiol. 2005;104(3):288-91.
34. Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol. 1997;145(8):762-9.
35. Tretli S, Lund-Larsen PG, Foss OP. Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county. J Epidemiol Community Health. 1982;36(4):269-73.
36. Gonzalez MM, Cavalcanti TC, Vianna CB, Timerman S. Hypomagnesaemia causing QT interval prolongation and torsade de pointes in an alcoholic patient. Resuscitation. 2006;70(3):346-7.
37. Trevisani F, Merli M, Savelli F, Valeriano V, Zambruni A, Riggio O, et al. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol. 2003;38(4):461-7.